Evidence map›Paper›PMID 42358285›Full record

ReviewPrecision radiation oncology2026

A new perspective on radiotherapy in the comprehensive treatment of cancer.

Yingze Ma, Hongxuan Yu, Shijie Shang, Shixin Shan, Dawei Chen

Abstract readReview
In one paragraph

Review in Precision radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yingze MaShandong University Cancer Center Shandong University Jinan Shandong China.
Hongxuan YuShandong University Cancer Center Shandong University Jinan Shandong China.
Shijie ShangDepartment of Radiation Oncology Shandong Provincial Key Laboratory of Precision Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences Jinan Shandong China.
Shixin ShanShandong Provincial Center for Disease Control and Prevention Jinan China.
Dawei ChenShandong University Cancer Center Shandong University Jinan Shandong China.ORCID https://orcid.org/0000-0002-6762-7997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiotherapy (RT) has become an indispensable part of modern cancer treatment owing to its efficacy, precision, and safety. With continuous advances in clinical practice, the role of RT in comprehensive cancer treatment has been repositioned. Through a combination of chemotherapy, targeted therapy, and immunotherapy, RT can achieve multiple therapeutic goals, including disease cure, symptom relief, improved quality of life, and prolonged survival. Therefore, understanding the development of RT, its mechanisms, technological innovations, combined therapeutic strategies, and prospects is essential for advancing tumor treatment and improving patient survival.

Indexed as

combination therapyfuture directionshistorical developmentradiotherapy

Identifiers

PMID42358285
PMCPMC13292160

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.